LEVEMOPAMIL
UNII TDE8767O88

Substance Identification & Data

This profile provides standardized clinical and technical data for Levemopamil, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TDE8767O88.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 101238-51-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

TDE8767O88

CAS Registry Number

101238-51-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEVEMOPAMIL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H30N2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DWAWDSVKAUWFHC-QHCPKHFHSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C81334

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

72027

Unique identification number in the NCBI database of chemical substances.

INN ID

6562

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@](c1ccccc1)(C#N)(C(C)C)CCCN(C)CCc2ccccc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Levemopamil. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.